Results 211 to 220 of about 362,523 (334)

Neurotransmitter receptor-associated gene signature: prognostic and immunosuppressive microenvironment in NSCLC. [PDF]

Future Sci OA
Yang Y, Ge A, Xu Y, Li J, Shi W, Wang J, Zhao Z.   +6 more
europepmc   +1 more source

Targeting the tumor-promoting microenvironment in MET-amplified NSCLC cells with a novel inhibitor of pro-HGF activation [PDF]

, 2017
Galemmo, Robert A, Jr, Han, Zhenfu, Janetka, James W, Klampfer, Lidija, Owusu, Benjamin Y, Thomas, Shantasia, Venukadasula, Phanindra   +6 more
core   +2 more sources

CRISPR Enabled Precision Oncology: From Gene Editing to Tumor Microenvironment Remodeling

Med Research, EarlyView.
CRISPR technology has progressed from a prokaryotic immune system to a diverse suite of editing platforms, including Cas nucleases, base and prime editors, and RNA‐targeting enzymes. These advances enable precise genomic and epigenomic interventions, high‐throughput functional screening, and immune engineering.
Kailai Li, Peixin Huang, Yue Qian, Anqi Lin, Jingjun He, Junyi Shen, Li Chen, Kai Miao, Jian Zhang   +8 more
wiley   +1 more source

Unlocking the potential of immunotherapy for patients with resectable non-small cell lung cancer. [PDF]

Front Oncol
Patel SP, Gainor J, Kao S, Lee SH, Mok T, Shah R, Zhou C, Peters S.   +7 more
europepmc   +1 more source

Advances and Prospects of Stereotactic Radiosurgery and Stereotactic Ablative Body Radiotherapy: Evolving Paradigms in Precision Oncology

Med Research, EarlyView.
The graphical abstract outlines the progressive development and impact of stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT). Technological Evolution illustrates the transition from brachytherapy with single‐dose, LDR/HDR schedules to fractionated radiotherapy, three‐dimensional conformal radiotherapy (3DCRT) and Gamma Knife ...
Jing Zhang, Wenhao Xu, Weiqing Lu, Yingxuan Lin, Luoxi He, Zonglin Lv, Yiliyaer Nuerrula, Zouting, Zhen Zhang, Hailiang Zhang, Xuejun Ma   +10 more
wiley   +1 more source

Real-world management of oral mucositis/stomatitis among patients with advanced non-small cell lung cancer (NSCLC) or breast cancer (BC). [PDF]

Future Oncol
Nguyen M, Shah R, Apple J, John W, Lucht S, Paydar C, Pathak P, Allen-Van Doren BA, Ahlquist M, Laney J, Feinberg B.   +10 more
europepmc   +1 more source

CCT3 Facilitates the Malignant Progression of NSCLC and SCLC via PI3 K/AKT-EMT Axis and Emerges as a Novel Serum Diagnostic Biomarker. [PDF]

Technol Cancer Res Treat
Song G, Han K, Xiang L, Peng T, Chen H, Tang A, Li Y, Lan T, Ying H, Cheng X.   +9 more
europepmc   +1 more source

PV-0277: SBRT with concurrent chemoradiation in stage III NSCLC: first results of the phase I Hybrid trial

, 2016
Heike Peulen, J.J. Sonke, Erik van der Bijl, E. Damen, J. Belderbos   +4 more
openalex   +1 more source

A Zosteriform Papular Cutaneous Eruption

JEADV Clinical Practice, EarlyView.
Silvia Borriello, Umberto Santaniello, Astrid Lappi, Paolo Borrelli, Angelo Battaglia, Roberta Patetta, Sophie Frassy, Simone Ribero, Pietro Quaglino   +8 more
wiley   +1 more source

A Canadian Perspective on Perioperative Systemic Therapy in Resectable Non-Small Cell Lung Cancer. [PDF]

Curr Oncol
Khan SR, Kotrri E, Breadner D, Kundapur V, Manna M.   +4 more
europepmc   +1 more source